A US federal court in Virginia rules that restrictions placed by the US drug regulator on the abortion pill mifepristone are “unlawful.” The court orders the Trump administration to reconsider the challenged rules tied to how and when the drug can be used. The decision centers on the legality of the restrictions rather than addressing abortion policy broadly.
Both outlets report that the ruling requires federal authorities to revisit the regulatory measures affecting mifepristone. The court’s order reflects findings that the regulator’s limits conflict with applicable legal requirements. The coverage also notes the court’s characterization of the restrictions as unlawful and frames the next step as administrative reconsideration by the Trump administration.
The reports do not indicate the specific details of the restrictions being overturned or the timeline for the administration’s response, but they consistently describe a federal court directive to reconsider mifepristone rules after the finding of illegality.
